Company Overview of Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc., a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its TRN-157 is a preclinical development program that focuses on the treatment of chronic obstructive pulmonary disease and severe asthma. The company was founded in 2008 and is based in Sunnyvale, California.
365 San Aleso Avenue
Sunnyvale, CA 94085
Founded in 2008
Key Executives for Theron Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Keraplast Technologies Ltd.||United States|
|Dilyx Biotechnologies, LLC||United States|
|CytImmune Sciences, Inc.||United States|
|Xylos Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Theron Pharmaceuticals, Inc., please visit www.theronpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.